A Design of Experiments for Tablet Compression - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A Design of Experiments for Tablet Compression
The author prepared and analyzed a detailed design of experiments for the manufacture of a simple tablet formulation. The aim was to test whether tablet hardness and weight could be controlled during the compression process by adjusting certain machine parameters.


Pharmaceutical Technology
Volume 35, Issue 9

Optimization study and discussion of response


Table VI: Analysis of variance for augmented central composite design model according to tablet weight.
Once the initial screening study and the augmented CCD study were concluded, sufficient data had been generated to support an optimization study. The optimization process provides an opportunity to set the two responses, hardness and weight, to desirable outcomes and allow Design-Expert software to produce recommended experiments that should yield tablets with the desired criteria. Optimization is the ultimate goal of any experimental-design process. In this case, a target hardness of 7 kP and a weight of 190 mg were selected. The upper and lower factor limits from the augmented CCD study were used during the optimization process, and eight experiments were performed.


Table VII: Optimization study results.
The results of this study were mixed. Two runs were acceptable, but the other six produced undesirable hardness. The results of the optimization experiments are shown in Table VII. For added benefit, output responses from the tablet press were recorded for precompression force and main compression force in kN. Although it would have been preferable to have several more factor setpoint combinations to produce the desired tablet characteristics, several hypotheses can explain why the other experiments did not produce the desired tablet.


Figure 7: 3D response plot for optimization run 7.
The predicted response 3D plot shows how optimization run 7 responded at the given factor setpoints shown in Table VII. In Figure 7, a small window is evident on the concentric rings in the x axis. The window shows that a limited range of error is permissible to maintain the desired hardness and weight values. The area in red on the 3D contour represents the most desirable response. Further studies could be performed in the small red region with the intent of clearly defining the acceptable factor tolerances when moving a product into a manufacturing environment.

High turret speeds can cause tablet weight to decrease, especially if the feed-frame paddles are turning slowly. This effect occurs when insufficient powder is placed into the tablet-punch die in the brief amount of time that it is under the feed frame. It is also possible that at such high radial velocities, high centrifugal forces push the powder fill out of the die.

When precompression or main compression forces were high, tablet defects were observed in the form of lamination. Lamination likely occurs when the tablet is compressed too quickly, causing the tablet to separate in layers. This defect was often associated with high turret speeds. Lamination may also result from inadequate removal of the entrapped air in the die cavity during the precompression step. A tablet that has begun to laminate may provide false readings on the hardness tester. Lamination was more prevalent when main compression forces were less than precompression forces.

Experienced formulation scientists and production operators understand the complexities of tablet-press operation, and this knowledge can help them to prepare targeted experimental designs that would produce optimization responses with great flexibility in the processing specification setpoints. As the processing specification setpoint error gets larger, the likelihood that the batch will be rejected for undesirable responses decreases. The larger the allowable variation from the processing setpoint, the greater the chance of producing an acceptable tablet.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here